EMA Grants Orphan Drug Designation to Elamipretide for Barth Syndrome
According to a recent news release from PR Newswire, the European Medicines Agency (EMA) has recently awarded elamipretide its Orphan Drug designation for the treatment of Barth syndrome. This treatment,…